Shopping Cart
- Remove All
- Your shopping cart is currently empty
KBU2046 is an orally administered compound that inhibits cell motility and invasion, effectively suppressing cancer metastasis and extending lifespan. This compound uniquely targets and binds to chaperone heterocomplexes, selectively modifying the interaction of client proteins involved in motility regulation, while avoiding the characteristics typical of classical HSP90 inhibitors.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $29 | In Stock | |
5 mg | $48 | In Stock | |
10 mg | $68 | In Stock | |
25 mg | $143 | In Stock | |
50 mg | $223 | In Stock | |
100 mg | $338 | In Stock | |
200 mg | $473 | In Stock | |
1 mL x 10 mM (in DMSO) | $53 | In Stock |
Description | KBU2046 is an orally administered compound that inhibits cell motility and invasion, effectively suppressing cancer metastasis and extending lifespan. This compound uniquely targets and binds to chaperone heterocomplexes, selectively modifying the interaction of client proteins involved in motility regulation, while avoiding the characteristics typical of classical HSP90 inhibitors. |
Molecular Weight | 242.24 |
Formula | C15H11FO2 |
Cas No. | 1143863-69-7 |
Smiles | Fc1ccc(cc1)C1COc2ccccc2C1=O |
Relative Density. | 1.31g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 45 mg/mL (185.77 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.